Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
Osterman MT, Aberra FN, Cross R, Liakos S, McCabe R, Shafran I, Wolf D, Hardi R, Nessel L, Brensinger C, Gilroy E, Lewis JD; DEAR Investigators.
Osterman MT, et al.
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1887-93.e3. doi: 10.1016/j.cgh.2014.03.035. Epub 2014 Apr 30.
Clin Gastroenterol Hepatol. 2014.
PMID: 24793028
Free PMC article.
Clinical Trial.